Patents by Inventor Patrick Bureau

Patrick Bureau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IAP BIR DOMAIN BINDING COMPOUNDS
    Publication number: 20090192140
    Abstract: Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a prodrug, or a pharmaceutically acceptable salt, or labeled with a detectable label or an affinity tag thereof; wherein R1, R1a, R100, R100a, R2, R200, W, B, and W1 are defined herein. Also disclosed are methods of using compounds of Formula I to treat proliferative disorders such as cancer.
    Type: Application
    Filed: May 16, 2007
    Publication date: July 30, 2009
    Applicant: Aegera Therapeutics Inc.
    Inventors: Alain Laurent, Scott Jarvis, Patrick Bureau, Alain Boudreault, James Jaquith
  • IAP BIR domain binding compounds
    Patent number: 7547724
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: June 16, 2009
    Assignee: Aegera Therpeutics, Inc.
    Inventors: Alain Laurent, Kim E. Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Publication number: 20080207525
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II or a salt thereof, in which R1, R2, R3, R100, R200, R300, A, A1, BG, Q and Q1 are substituents described herein. Also disclosed is the use of compounds of Formula I and II to treat proliferative disorders such as cancer.
    Type: Application
    Filed: November 1, 2007
    Publication date: August 28, 2008
    Inventors: Alain Boudreault, James B. Jaquith, Patrick Bureau, John W. Gillard
  • IAP BIR domain binding compounds
    Publication number: 20080014207
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 1, 2006
    Publication date: January 17, 2008
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Publication number: 20070219140
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substitutents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 4, 2006
    Publication date: September 20, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • IAP BIR domain binding compounds
    Publication number: 20070093429
    Abstract: Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.
    Type: Application
    Filed: December 4, 2006
    Publication date: April 26, 2007
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: Alain Laurent, Kim Hewitt, Stephen Morris, Patrick Bureau, Alain Boudreault, Scott Jarvis, James Jaquith
  • BIR domain binding compounds
    Publication number: 20060264379
    Abstract: The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: in which the substituents R1, R1a, R2, R2a, R3, A and Q are defined herein; or a prodrug, or a salt thereof, and which bind to IAP BIR domains.
    Type: Application
    Filed: May 16, 2006
    Publication date: November 23, 2006
    Inventors: Scott Jarvis, Alain Boudreault, Patrick Bureau, James Jaquith, Alain Laurent, Delphine Labit
  • Method of modulation and demodulation of a digital signal, in particular in a frequency band affected by flat fading, associated modulator and demodulator
    Publication number: 20060133520
    Abstract: A method of modulating a digital signal of width L in frequency on a given useful frequency band is described The digital signal is separated into N blocks bn (1?n?N). The given useful frequency band is split into N contiguous parts Pn. Channels Cn, of width ln in frequency, lying within an associated part Pn, are defined. The channels Cn are separated, a distributing of each block of digital signals bn over the associated channel Cn.
    Type: Application
    Filed: December 15, 2003
    Publication date: June 22, 2006
    Inventors: Bruno Le Breton, Pierre Vasseur, Patrick Bureau
  • Imidazo(2,1-b)-1,3,4-thiadiazole sulfoxides and sulfones
    Publication number: 20060135571
    Abstract: This invention relates to novel imidazo[2,1-b]-1,3,4-thiadiazole sulfoxide and sulfone compounds of Formula (I) and the use of compounds of Formula (I) in the treatment of neuronal disorders of the central and peripheral nervous systems and for the treatment of proliferative diseases such as cancer.
    Type: Application
    Filed: June 14, 2004
    Publication date: June 22, 2006
    Inventors: James Jaquith, John Gillard, Patrick Bureau, Scott Jarvis